Market
BSE Prices delayed by 5 minutes... << Prices as on Jun 16, 2026 >>  ABB India  7017.2 [ 1.32% ] ACC  1349.8 [ -0.58% ] Ambuja Cements  426.2 [ -0.54% ] Asian Paints  2748.8 [ 0.35% ] Axis Bank  1365.8 [ -0.18% ] Bajaj Auto  9934.1 [ -0.09% ] Bank of Baroda  275.3 [ -0.22% ] Bharti Airtel  1855.2 [ 0.78% ] Bharat Heavy  384.15 [ 0.33% ] Bharat Petroleum  311.8 [ 0.45% ] Britannia Industries  5217.2 [ 0.39% ] Cipla  1372.75 [ -0.63% ] Coal India  451 [ 1.38% ] Colgate Palm  2097.1 [ 1.88% ] Dabur India  435.7 [ 1.54% ] DLF  629.7 [ 2.72% ] Dr. Reddy's Lab.  1277.05 [ -0.17% ] GAIL (India)  176.1 [ 0.34% ] Grasim Industries  3138.7 [ -0.70% ] HCL Technologies  1159.35 [ 3.59% ] HDFC Bank  784.7 [ 0.96% ] Hero MotoCorp  5032.1 [ 0.19% ] Hindustan Unilever  2201.15 [ 2.10% ] Hindalco Industries  982.4 [ -3.04% ] ICICI Bank  1334.9 [ 0.54% ] Indian Hotels Co.  694.3 [ 0.64% ] IndusInd Bank  925.75 [ -0.79% ] Infosys  1143.3 [ 0.71% ] ITC  291.75 [ 1.32% ] Jindal Steel  1139.75 [ -0.87% ] Kotak Mahindra Bank  408.1 [ 0.60% ] L&T  4185.7 [ 0.34% ] Lupin  2277 [ 0.15% ] Mahi. & Mahi  3137.8 [ 0.09% ] Maruti Suzuki India  13692.85 [ -0.81% ] MTNL  31.25 [ 0.42% ] Nestle India  1391.6 [ 1.25% ] NIIT  106.32 [ 19.13% ] NMDC  88.07 [ -0.42% ] NTPC  355.45 [ 2.10% ] ONGC  248.25 [ 1.87% ] Punj. NationlBak  107.95 [ 0.05% ] Power Grid Corpn.  285.15 [ -0.16% ] Reliance Industries  1327.85 [ 1.59% ] SBI  1015.5 [ -0.49% ] Vedanta  300 [ -0.86% ] Shipping Corpn.  308.45 [ -0.79% ] Sun Pharmaceutical  1800.65 [ -0.32% ] Tata Chemicals  729.6 [ -0.77% ] Tata Consumer  1129.45 [ 2.64% ] Tata Motors Passenge  393.6 [ -0.82% ] Tata Steel  196 [ -0.71% ] Tata Power Co.  402.1 [ -0.45% ] Tata Consult. Serv.  2198.85 [ 1.72% ] Tech Mahindra  1446.1 [ 1.45% ] UltraTech Cement  11388.95 [ -0.74% ] United Spirits  1299.15 [ 2.20% ] Wipro  182.7 [ 0.72% ] Zee Entertainment  111.29 [ 2.48% ] 
Zim Laboratories Ltd. Notes to Accounts
Search Company 
You can view the entire text of Notes to accounts of the company for the latest year
Market Cap. (Rs.) 595.63 Cr. P/BV 2.01 Book Value (Rs.) 55.31
52 Week High/Low (Rs.) 127/59 FV/ML 10/1 P/E(X) 102.05
Bookclosure 27/06/2024 EPS (Rs.) 1.09 Div Yield (%) 0.00
Year End :2026-03 

(i) There are no advances to directors or other officers of the Company either severally or jointly with any other person or debts due by firms or private companies respectively in which any director is a partner or director or a member other than those disclose in the note 43.

(ii) The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including foreign entities (Intermediaries) with the understanding that the Intermediary shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

(iii) The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party) with the understanding (whether recorded in writing or otherwise) that the Company shall:

a. directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries) or

b. provide any guarantee, security or the like on behalf of the ultimate beneficiaries.

(b) Rights, preferences and restrictions

The Company has one class of equity shares having a par value of ' 10 per share. Each shareholder is eligible for one vote per share held. The dividend proposed by the Board of Directors is subject to the approval of the shareholders at the ensuing Annual General Meeting, except in case of interim dividend. In the event of liquidation, the equity shareholders are eligible to receive the remaining assets of the Company after distribution of all preferential amounts, in proportion to their shareholding.

(c) Bonus shares issued

On 12 December 2022, the Company has issued 32,483,876 equity shares of face value ' 10 each as fully paid up bonus shares. The Company has issued two bonus equity shares against one equity share held by its shareholders.

(d) Equity shares reserved for issue under employee stock options

For number of stock options against which equity shares to be issued by the Company upon vesting and exercise of those stock options and rights by the employees under Employee Stock Option Scheme. (Refer note 47)

Nature of security and terms of repayment for secured borrowings

(i) Loan from a bank and a NBFC are secured by way of first charge on all present and future property, plant and equipment including Land & Building, Plant & Machinery and second charge on all current assets on pari passu basis with lead banker & other members under consortium arrangement. The loans are also secured by personal guarantee of managing director.

A Disclosure as per Ind AS 115

The operations of the Company are limited to only one segment viz. pharmaceuticals and related products. Revenue from contract with customers is from sale of manufactured goods and rendering of research services. Sale of goods are made at a point in time and revenue is recognised upon satisfaction of the performance obligations which is typically upon dispatch / delivery. The Company has a credit evaluation policy based on which the credit limits for the trade receivables are established. There is no significant financing component as the credit period provided by the Company is not significant.

There are no significant variable components such as discounts, rebates, sales returns etc.

37 Fair value measurements

Financial instruments by category:

All financial assets and financial liabilities, except investment in equity shares (not made in subsidiaries) of the Company are under the amortised cost measurement category at each of the reporting date.

Fair value hierarchy

The fair values of the financial assets and liabilities are included at the amount that would be received on selling of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

This section explains the judgements and estimates made in determining the fair values of the financial instruments that are (a) recognised and measured at fair value and (b) measured at amortised cost and for which fair values are disclosed in the financial statements.

To provide an indication about the reliability of the inputs used in determining fair value, the Company uses the following hierarchy for determining and disclosing the fair value of the financial instruments by valuation technique.

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs that have a significant effect on the recorded fair value that are not based on observable market data.

During the periods mentioned above, there have been no transfers amongst the levels of hierarchy.

The carrying amounts of security deposits, trade receivables, current loans, other financial assets, fixed deposits with banks, current borrowings, trade payables, lease liabilities and other current financial liabilities are considered to be approximately equal to their fair value.

Valuation processes

The Company evaluates the fair value of financial assets and financial liabilities on periodic basis using the best and most relevant data available.

38 Financial risk management

The Company's financial risk management is an integral part of how to plan and execute its business strategies. The Company's financial risk management policy is set by the Risk Committee.

The Company is exposed to market risk, credit risk and liquidity risk.

A Market risk

Market risk is the risk of loss of future earnings, fair values or future cash flows that may result from a change in the price of a financial instrument. The value of a financial instrument may change as a result of changes in the interest rates, foreign currency exchange rates, equity prices and other market changes that affect market risk sensitive instruments. Market risk is attributable to all market risk sensitive financial instruments including deposits , foreign currency receivables, payables and loans and borrowings.

The Company manages market risk through a treasury department, which evaluates and exercises independent control over the entire process of market risk management. The treasury department recommend risk management objectives and policies, which are approved by Chief financial officer. The activities of this department include management of cash resources, implementing hedging strategies for foreign currency exposures like foreign exchange forward contracts, borrowing strategies and ensuring compliance with market risk limits and policies.

Market risk - Interest rate risk

Interest rate risk is the risk that the fair value of future cash flows of the financial instruments will fluctuate because of changes in market interest rates. In order to optimize the Company's position with regards to interest income and interest expenses and to manage the interest rate risk, treasury performs a comprehensive corporate interest rate risk management by balancing the proportion of fixed rate and floating rate financial instruments in its total portfolio.

According to the Company, interest rate risk exposure is only for floating rate borrowings. For floating rate liabilities, the analysis is prepared assuming the amount of the liability outstanding at the end of the reporting period was outstanding for the whole year. A 50 basis point increase or decrease is used when reporting interest rate risk internally to key management personnel and represents management's assessment of the reasonably possible change in interest rates.

B Credit risk

The Company considers the probability of default upon initial recognition of asset and whether there has been a significant increase in credit risk on an ongoing basis through each reporting period. To assess whether there is a significant increase in credit risk the Company compares the risk of default occurring on asset as at the reporting date with the risk of default as at the date of initial recognition. It considers reasonable and supportive forwardinglooking information such as:

i) Actual or expected significant adverse changes in business,

ii) Actual or expected significant changes in the operating results of the counterparty,

iii) Financial or economic conditions that are expected to cause a significant change to the counterparty's ability to meet its obligations,

iv) Significant increase in credit risk on other financial instruments of the same counterparty,

v) Significant changes in the value of the collateral supporting the obligation or in the quality of the third-party guarantees or credit enhancements .

Financial assets are written off when there is no reasonable expectations of recovery, such as a debtor failing to engage in a repayment plan with the Company. Where loans or receivables have been written off, the Company continues to engage in enforcement activity to attempt to recover the receivable due. Where recoveries are made, these are recognized as income in the statement of profit and loss.

The presumption under Ind AS 109 with reference to significant increase in credit risk since initial recognition (when financial assets are more than 30 days past due), has been rebutted and is not applicable to the Company, as the Company is able to collect a significant portion of its receivables that exceed the due date and the receivables past due by 90 days are considered generally as significant increase in credit risk.

Credit risk management

To manage credit risk, the Company periodically assesses the financial reliability of customers and other counterparties, taking into account the financial condition, current economic trends, analysis of historical bad debts and ageing of accounts receivable. Individual risk limits are set accordingly. There is no significant concentration of credit risk.

Bank balances are held with only high rated banks and majority of security deposits are placed majorly with government agencies. Trade receivables are generally recovered within the credit period. The Company measures the expected credit loss of trade receivables and loan from individual customers based on historical trend, industry practices and the business environment in which the entity operates. Loss rates are based on actual credit loss experience and past trends. Based on the historical data, loss on collection of receivable is not material hence no additional provision considered.

C Liquidity risk

Liquidity risk is defined as the risk that the Company will not be able to settle or meet its obligations on time or at a reasonable price. For the Company, liquidity risk arises from obligations on account of financial liabilities - borrowings, trade payables, lease liabilities and other financial liabilities.

Liquidity risk management

The Company’s corporate treasury department is responsible for liquidity and funding as well as settlement management. The processes and policies related to such risks are overseen by Chief financial officer. Management monitors the Company’s net liquidity position through rolling forecasts on the basis of expected cash flows.

39 Capital management Risk management

The Company’s objectives when managing capital are to

• safeguard their ability to continue as a going concern, so that they can continue to provide returns for shareholders and benefits for other stakeholders, and

• maintain an optimal capital structure to reduce the cost of capital.

44 Contingent liabilities and commitments (A) Contingent liabilities

' in lakhs

As at 31 March 2026

As at

31 March 2025

Income Tax Assessments for earlier years for disallowance of expenditure, pending in appeal

395.95

28.73

585.07

395.95

Input tax credit mismatch under GST, pending in appeal

-

Import Duty saved under the Advance License scheme considering export obligation to be fulfilled within the period allowed

57.89

Notes:

1. The Company does not expect any reimbursement in respect of the above contingent liabilities.

2. It is not practical to estimate the timing of cash outflows, if any, in respect of matters above, pending resolution/completion of the appellate proceedings/other proceedings, as applicable.

(B) Commitments

' in lakhs

As at 31 March 2026

As at

31 March 2025

Estimated value of contracts in capital account remaining to be executed (net of capital advance)

1,100.09

1,117.88

(b) Defined Benefits Plan :

Gratuity

Under the gratuity plan, every employee is entitled to the benefit equivalent to fifteen days salary (as per last drawn salary) for each completed year of service or part thereof in excess of six months depending on the date of joining and eligibility terms, in terms of provisions of the Payment of Gratuity Act,1972 and Code on Wages, 2019. The same is payable on termination of service or retirement, whichever is earlier. The benefit vests after five years of continuous service for permanent employees and one years of continuous service for fixed term employees. Liabilities for such benefits are provided on the basis of valuation, as at the balance sheet date, carried out by an independent actuary. The actuarial valuation method used by an independent actuary for measuring the liability is the Projected Unit Credit method. The scheme is funded with an insurance company in the form of qualifying insurance policy for permanent employees and unfunded for fixed term employees classified as part of "Contractual services"

Changes to Employee Benefits upon notification of Labour Codes

The Government of India notified the Code on Wages , 2019, the Industrial Relations Code, 2020, the Code on Social Security , 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively, the "Labour Codes"). These Labour Codes, which have become effective from 21 November 2025, consolidate and rationalise 29 labour laws and introduce, among other matters, a uniform definition of "Wages". Also the Labour Codes have modified certain employee benefits and eligibility conditions in respect of those benefits. Accordingly, during the year, the Company has recognised past service cost on account of eligibility of fixed term employees under Gratuity benefits in the Statement of Profit and Loss and classified as part of "Contractual services".

(c) Compensated absences

The Company’s liability is actuarially determined (using the Projected Unit Credit method) at the end of each year and net charge to the Statement of Profit and Loss for the year under "Employee benefits expenses" is ' 226.76 lakhs (Previous Year: ' 205.89 lakhs) and under "Contractual services" is ' 3.15 lakhs (Previous Year: ' Nil).

46 Segment information

The Company is primarily engaged in the business of pharmaceuticals. The Company has entrusted decision making authority to the Managing Director (highest authority) who is the Chief Operating Decision Maker (CODM) who has complete control over the operating decisions and is responsible for the information presented to the Board of Directors. Managing Director reviews the Company's performance based on the analysis of the Profit Before Tax ( PBT) at an overall entity level and therefore there is no other separate reportable segment for the Company as defined by Ind AS 108 "Operating Segment".

Resolution passed by Nomination & Remuneration committee and Board at its meeting dated 23 December 2023 and the shareholders through postal ballot on 28 January 2024 had approved the ‘ZIM Laboratories Employee Stock Option Scheme 2023’ (“ESOS 2023”/ “Scheme”), to create, offer, issue, grant and allot from time to time, in one or more tranches, not exceeding 994,404 (Nine Lakhs Ninety-four Thousand Four Hundred and Four) employee stock options (“Options”) to the eligible employees of the Company and/or its subsidiary companies exercisable into not more than 994,404 (Nine Lakhs Ninety-four Thousand Four Hundred and Four) equity shares.

During the previous year, The Nomination and Remuneration Committee in its meeting held on 13 April 2024 granted 687,257 options to the eligible employees of the Company and the subsidiary at an exercise price of ' 77.40. Remaining options of 307,147 are available in the ESOP Pool to be granted to the employees of the Company and its subsidiaries.

a) Earnings for Debt Service = Net Profit after tax Depreciation and amortisation expense Finance costs (recognised excluding lease), Debt Service = Principal Repayments Finance costs (recognised excluding lease).

b) Average Trade Payables = Average Trade payables for the materials purchase.

c) Working Capital = Current Assets - Current Liabilities.

d) Earnings before Interest and Tax = Profit before tax Finance costs (recognised excluding lease).

e) Capital Employed = Average of equity and total borrowings.

f) The Company has investments in subsidiaries and other insignificant trade investment.

Reasons for ratio variances exceeding 25%.

i) Debt Service Coverage Ratio: Decreased by 32% in the current year due to decrease in profitability and increased finance costs and borrowings of the Company.

(ii) Return on Equity Ratio: Decreased by 54% in the current year due to decrease in profitability of the Company.

(iii) Net Capital Turover Ratio : Decreased by 26% in the current year due to increased working capital of the Company.

(iv) Net Profit Ratio: Decreased by 48% in the current year due to decrease in profitability and increased finance costs of the Company.

(v) Return on Capital Employed: Decreased by 32% in the current year due to decrease in profitability of the Company.

(vi) Basic EPS: Decreased by 49% in the current year due to decrease in profitability of the Company.

(vii) Interest coverage ratio : Decreased by 36% in the current year is mainly due to decrease in profitability and increased finance costs on account of working capital.

51 The Company has used an accounting software for maintaining its books of accounts for the year ended 31 March 2026 which has a feature of recording audit trail (edit log) facility and the audit trail feature at the application level has operated throughout

the year for all relevant transactions recorded in the software. However, with respect to audit trail at database level, audit trail login was available but DML (Data Manipulation Language) operations relating to change data was not enabled. Subsequent to the year ended 31 March 2026, the Company has enabled DML operations relating to change data at database level. Additionally, the audit trail that was enabled and operated at application level for the year ended 31 March 2026 has been preserved by the Company as per the statutory requirements for record retention.

53 Figures of the previous year has been re-grouped/re-arranged wherever necessary. The impact of the same is not material to the users of standalone financial statements.



 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by